Artaç, M. Et Al. 2016. Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.. Clinical genitourinary cancer , vol.14 .

Artaç, M., Çoşkun, H. Ş., Korkmaz, L., Koçer, M., Turhal, N. S., Engin, H., ... Dede, İ.(2016). Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.. Clinical genitourinary cancer , vol.14.

Artaç, Mehmet Et Al. "Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.," Clinical genitourinary cancer , vol.14, 2016

Artaç, Mehmet Et Al. "Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.." Clinical genitourinary cancer , vol.14, 2016

Artaç, M. Et Al. (2016) . "Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.." Clinical genitourinary cancer , vol.14.

@article{article, author={Mehmet Artaç Et Al. }, title={Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study.}, journal={Clinical genitourinary cancer}, year=2016}